Sales & Support: +44 (0)1223 316 855

Cambridge Bioscience and Research Donors join Nordic BioSite Group


9th March 2022

Life science research distributor Nordic BioSite Group acquires UK distributor Cambridge Bioscience, and biospecimens provider Research Donors, to expand geographical footprint and add new product areas to portfolio. Through these acquisitions Nordic BioSite Group furthers its goal of becoming an even stronger partner to its suppliers and customers.

Nordic BioSite Group (NBG) is a leading European supplier of research and diagnostics products, with a particularly strong position within the antibody and other research reagent markets. Through the combination of Nordic BioSite AB in the Nordics, Sanbio BV in Benelux, Biomol GmbH in Germany and Szabo Scandic in Austria, the Group has built a solid presence in Northern Europe. In adding British Cambridge Bioscience to the network, the Group will be able to better represent its suppliers and bring new products to customers. Research Donors, a biospecimens company focusing on highly specified human blood products, will bring an exciting new product area to the Group’s existing European customer base.

“We see strong potential for creating a pan-European life science research distributor, serving suppliers across Europe. The intensity and quality of British life science research made the UK a natural next step in our growing geographical footprint. Cambridge Bioscience was the clear choice given their excellent reputation amongst both suppliers and customers. In our constant efforts to better serve our customers we identified human biospecimens as a key enabler of life science research and as a gap in our current portfolio – hence we see strong logic for acquisition of Research Donors, a London based high-quality provider of biospecimens” says CEO Wilco van Hamond.

Mike Kerins, Managing Director of Cambridge Bioscience and founder of Research Donors, will continue to lead UK operations as well as supporting the Group on strategic development. Commenting on the acquisitions he said; “The consolidation of the European life science distribution market will generate value for suppliers and customers, and I see a bright future for both Cambridge Bioscience and Research Donors as part of the fast growing Nordic BioSite Group”.

“We are impressed by the management teams in both Cambridge Bioscience and Research Donors and recognise that the companies’ services are of great value to their suppliers and customers. The board looks forward to continuing to support NBG in building the leading pan-European life science research distributor,” says Lene Stern, chairman of the board of NBG.

The parties have chosen not to disclose the financial terms of the transaction. 

For further information: 
Nordic BioSite: Wilco van Hamond, wilco.vanhamond@nordicbiosite.com, +31 653 94 19 04
Cambridge Bioscience/Research Donors; Mike Kerins, mike.kerins@bioscience.co.uk, +44 1223 316 855

About Nordic BioSite Group 
Nordic BioSite has been a leading supplier of products for research and diagnostics for over 20 years. Together with Sanbio (Benelux), BioMol (Germany), Szabo Scandic (Austria) the Group has a highly skilled employee base across Europe who provide products, expertise and support to thousands of researchers. For further information please visit https://www.nordicbiosite.com

About Cambridge Bioscience
Cambridge Bioscience has been a leading distributor of life science products for over 30 years in its home markets, the UK and the Republic of Ireland. Its highly qualified employees support local customers in gaining access to innovative products from top quality global life science manufacturers. For further information please visit https://www.bioscience.co.uk

About Research Donors
Research Donors was founded in 2018 to meet the needs of biomedical researchers for fresh, highly defined human blood biospecimens to enable precision medicine and immunology-orientated research. It collects, processes and supplies biospecimens from a large pool of healthy volunteer donors. The London based facility is licensed by the UK Human Tissue Authority and follows the most stringent processes for ethics and consent. For further information please visit https://researchdonors.co.uk